Chenying Zeng

1.3k total citations · 1 hit paper
30 papers, 1.0k citations indexed

About

Chenying Zeng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Chenying Zeng has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Chenying Zeng's work include MicroRNA in disease regulation (7 papers), Inflammasome and immune disorders (6 papers) and Circular RNAs in diseases (6 papers). Chenying Zeng is often cited by papers focused on MicroRNA in disease regulation (7 papers), Inflammasome and immune disorders (6 papers) and Circular RNAs in diseases (6 papers). Chenying Zeng collaborates with scholars based in China, United States and Hong Kong. Chenying Zeng's co-authors include Dong‐Yun Ouyang, Xian‐Hui He, Lihui Xu, Chenguang Li, Feng‐Yi Mai, Qiongzhen Zeng, Chengcheng Zhang, Bo Hu, Yaofeng Wang and Jing‐Ping Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Cellular and Molecular Life Sciences.

In The Last Decade

Chenying Zeng

25 papers receiving 1.0k citations

Hit Papers

Chemotherapeutic paclitaxel and cisplatin differentially ... 2019 2026 2021 2023 2019 100 200 300

Peers

Chenying Zeng
Chenying Zeng
Citations per year, relative to Chenying Zeng Chenying Zeng (= 1×) peers Lianwen Yuan

Countries citing papers authored by Chenying Zeng

Since Specialization
Citations

This map shows the geographic impact of Chenying Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenying Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenying Zeng more than expected).

Fields of papers citing papers by Chenying Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenying Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenying Zeng. The network helps show where Chenying Zeng may publish in the future.

Co-authorship network of co-authors of Chenying Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Chenying Zeng. A scholar is included among the top collaborators of Chenying Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenying Zeng. Chenying Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jingfan, Chenying Zeng, Yimin Chen, et al.. (2025). [Mechanism of Guben Jiannao Liquid on Alzheimer's disease by regulating autophagy based on LKB1/AMPK/mTOR pathway].. PubMed. 50(2). 293–300.
3.
Lin, Jiajie, Zhikun Li, Zheng Guan, et al.. (2025). Neutrophil extracellular traps exacerbate inflammatory arthritis by inhibiting γδ Treg cell differentiation via the AIM2 inflammasome. Redox Biology. 87. 103881–103881.
4.
Yu, Wenhui, Pei Feng, Chenying Zeng, et al.. (2025). Circular RNA circSTX12 regulates osteo-adipogenic balance and proliferation of BMSCs in senile osteoporosis. Cellular and Molecular Life Sciences. 82(1). 149–149. 3 indexed citations
5.
Guo, Linghong, Dandan Chen, Yan Gong, et al.. (2025). A retrospective observational study on the prognostic role of inflammatory markers in futile recanalization after endovascular treatment for large-vessel stroke. Journal of International Medical Research. 53(7). 3659420402–3659420402.
6.
Xie, Zhongyu, Jiajie Lin, Wenhui Yu, et al.. (2023). The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment. JCI Insight. 8(6). 9 indexed citations
7.
Guan, Zheng, Yunhui Zhang, Peng Wang, et al.. (2023). A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone formation. Journal of Nanobiotechnology. 21(1). 168–168. 15 indexed citations
8.
Chen, Fenglei, Shan Wang, Chenying Zeng, et al.. (2023). Silencing circSERPINE2 restrains mesenchymal stem cell senescence via the YBX3/PCNA/p21 axis. Cellular and Molecular Life Sciences. 80(11). 325–325. 14 indexed citations
9.
Feng, Pei, Zhongyu Xie, Tingting Chen, et al.. (2023). Enhancer-mediated FOXO3 expression promotes MSC adipogenic differentiation by activating autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166975–166975. 4 indexed citations
11.
Lin, Jiajie, Zhongyu Xie, Zhaoqiang Zhang, et al.. (2022). LncRNA MRF drives the regulatory function on monocyte recruitment and polarization through HNRNPD-MCP1 axis in mesenchymal stem cells. Journal of Biomedical Science. 29(1). 73–73. 5 indexed citations
12.
Huang, Wenlin, et al.. (2019). ATG3, a Target of miR-431-5p, Promotes Proliferation and Invasion of Colon Cancer via Promoting Autophagy. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Zhang, Chengcheng, Chenguang Li, Yaofeng Wang, et al.. (2019). Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation. APOPTOSIS. 24(3-4). 312–325. 356 indexed citations breakdown →
14.
Li, Chenguang, Qiongzhen Zeng, Mingye Chen, et al.. (2019). Evodiamine Augments NLRP3 Inflammasome Activation and Anti-bacterial Responses Through Inducing α-Tubulin Acetylation. Frontiers in Pharmacology. 10. 290–290. 59 indexed citations
15.
Yang, Fan, et al.. (2019). Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages. Frontiers in Immunology. 10. 72–72. 61 indexed citations
16.
Liu, Yi, Chenying Zeng, Chenguang Li, et al.. (2018). Scutellarin Suppresses NLRP3 Inflammasome Activation in Macrophages and Protects Mice against Bacterial Sepsis. Frontiers in Pharmacology. 8. 975–975. 79 indexed citations
17.
Wang, Jian, et al.. (2013). Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study. Nephrology Dialysis Transplantation. 28(9). 2339–2345. 26 indexed citations
18.
Zhang, Jing‐Ping, Chenying Zeng, Liu Xu, et al.. (2013). MicroRNA-148a suppresses the epithelial–mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene. 33(31). 4069–4076. 133 indexed citations
19.
Ke, Zunfu, et al.. (2011). Mutation characteristics in type I collagen genes in Chinese patients with osteogenesis imperfecta. Genetics and Molecular Research. 10(1). 177–185. 5 indexed citations
20.
Hua, Hongxia, et al.. (2005). Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension. Journal of Human Hypertension. 19(9). 715–721. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026